Penumbra, Inc. (PEN) by event type
PEN moves most on analyst downgrades — a median of +0.65% at 30 minutes across 48 measured events. Each row is measured over the last three years and read against the price at its own news timestamp. Back to the PEN overview →
How PEN reacts across 6 measured event types.
| Event | Events | Median 30-min | % positive | Median to close |
|---|---|---|---|---|
| Analyst upgrades 684 of 2,717 | 18 | +0.26% | 56% | -0.03% |
| Analyst downgrades 278 of 2,603 | 48 | +0.65% | 88% | +0.47% |
| Coverage initiations 682 of 2,283 | 19 | +0.23% | 63% | -0.08% |
| Rating reiterations 415 of 3,522 | 112 | +0.22% | 61% | +0.09% |
| Price-target raises 1,463 of 1,790 | 37 | -0.14% | 35% | +0.39% |
| Price-target cuts 1,040 of 1,527 | 23 | -0.09% | 39% | -0.18% |
Last 3 years, pulled 2026-09-21. Reaction = percent move vs. the price at the news timestamp. Counts and medians only. The rank under each event type orders every name measured for it by median 30-min reaction, most positive first — so a low rank on a downgrade means this name falls harder than most, not that it moves less. Names with an identical median share a rank; a name the cross-section does not carry shows no rank rather than a guessed one.
That’s how PEN usually reacts — get an email when it moves on news →Every name measured for these event types: Analyst upgrades → · Analyst downgrades → · Coverage initiations → · Rating reiterations → · Price-target raises → · Price-target cuts → · PEN overview →
Other Healthcare names, measured the same way
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| RITTER PHARMACEUTICALS (RTTR) | 374 | -0.61% | 37% |
| MIRAGEN THERAPEUTICS INC (MGEN) | 369 | -0.39% | 39% |
| Kura Oncology, Inc. (KURA) | 368 | -0.13% | 49% |
| Arcus Biosciences, Inc. (RCUS) | 368 | -0.09% | 45% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not.